Senators push back on proposed $18B NIH budget cut

The NIH director faced sharp questions on Tuesday from Republican and Democratic members of a Senate appropriations subcommittee

June 10, 2025 Check out STAT+

Sponsored By

Don't miss this deal: Get 50% off an annual subscription to STAT+ and stay up to date on the latest news coming out of the biotech, pharma, and life science industries.

TING SHEN/AFP via Getty Images STAT+ | Senators push back on Trump's proposed $18 billion NIH budget cut Lawmakers struggled to reconcile Jay Bhattacharya's stated commitment to research with the Trump administration's proposed NIH spending cuts By Jonathan Wosen STAT+ | NIH restores DEI prohibition for grant recipients within hours of rescinding it After rescinding ban on grants going to institutions with DEI or Israel boycott policies, NIH officials say the ban is still in effect By Anil Oza STAT+ | As drug price target deadline looms, pharma companies weigh options Trump's most-favored nation plan would tie U.S. drug prices to those in other countries. Pharma firms await details, worry about consequences. By Daniel Payne Annie Rice/AP Opinion: RFK Jr.'s attack on vaccine experts endangers every American  RFK Jr.'s decision to fire ACIP's members will make it far more difficult for pediatricians to vaccinate children. By Richard Besser STAT+ | Congressional report alleges organ procurement groups use loophole to boost ratings The senators say their investigation shows that more transparency and federal oversight of the transplant groups is needed. By Chelsea Cirruzzo Merck's RSV antibody treatment for infants is approved by FDA The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment. By Helen Branswell TOLGA AKMEN/AFP via Getty Images Opinion: We have 'post-vaccination syndrome.' We are tired of being used to score anti-vax points Yale's LISTEN study of post-vaccination syndrome became a lightning rod for Covid policy critics. Study participants want new treatments, not politics. By Chad Abel-Kops, Kimberly M. Harmon, and Peg Seminario STAT+ | Opinion: HBCUs can help create a 21st-century bioeconomy and the talent pipeline it requires Most traditional training programs do not prepare students to work in genomic analysis, molecular modeling, or AI-based diagnostics. By Karl M. Thompson

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser